Fibovil

Founded: 2019 • Age: 7 yrs
Pharmaceutical manufacturing and franchise services in India.

About Fibovil

Fibovil is a Healthcare company founded in 2019. Pharmaceutical manufacturing and franchise services in India. The company has 1 employees. Its Indian entity Fibovil Pharmaceuticals Private Limited reported revenue of β‚Ή36.82 Cr. Fibovil offers products and services including Tablets and PCD Pharma Franchise. Its focus areas include Services, Franchise Distribution, Marketing and Sales and Pharmaceuticals.

Company details

Fibovil is recognized for offering PCD Pharma franchises and a wide range of pharmaceutical products, with quality assurance maintained through WHOGMPGLP certifications. Over 3000 products are supplied across various therapeutic areas, including tablets, capsules, and injections, to meet patient needs in the Indian market. Research and development efforts are directed towards cost-effective solutions, bridging gaps in healthcare with experienced insights in the sector. Environmental protection is prioritized in manufacturing processes.

Key Metrics
  • Indian entity revenue
    ₹36.82 Cr

    FY 2025 · +22% YoY

  • Indian entity net profit
    ₹2.07 Cr

    FY 2025 · 6% margin

  • Indian entity EBITDA
    ₹4.31 Cr

    FY 2025 · 12% margin

  • Employee Count
    1

Products & Services of Fibovil

Fibovil offers a comprehensive portfolio of products and services, including Tablets and PCD Pharma Franchise.

Tablets
Pharmaceutical Products

Tablets are manufactured and supplied for various therapeutic uses across different segments

PCD Pharma Franchise
Services

Franchise opportunities are provided for the distribution of pharmaceutical products in specified regions

Board of directors of Fibovil Pharmaceuticals Private Limited (Fibovil)

Fibovil Pharmaceuticals Private Limited is the primary company behind Fibovil. The board of Fibovil Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Sahil, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Sahil
DIN 08421065
Director12 Apr 20197 yrs 6 moFibovil Pharmaceuticals Private Limited
Reetu Rani
DIN 08421066
Director12 Apr 20197 yrs 6 moFibovil Pharmaceuticals Private Limited
Jagat Parkash
DIN 09643125
Director20 Jun 20224 yrs 4 moFibovil Pharmaceuticals Private Limited

Financials of Fibovil

Figures of Fibovil Pharmaceuticals Private Limited, the primary company behind Fibovil, for FY 2025. Revenue was ₹36.82 Cr (+22% year on year). Net profit was ₹2.07 Cr (6% margin). EBITDA was ₹4.31 Cr (12% margin). Revenue has grown at a compounded annual rate of +41% over three years and +67% over five years.

  • ₹36.82 CrRevenue · FY 2025 · +22% YoY
  • ₹2.07 CrNet profit · 6% margin
  • ₹4.31 CrEBITDA · 12% margin
  • ₹1 LakhPaid-up capital
  • 25Employees (provident fund records)
  • +41%Revenue CAGR, 3 years
  • +67%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Fibovil Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Fibovil

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Fibovil

Websites that share an audience with Fibovil (fibovil.com).

Similar websites

Websites whose visitors overlap most with Fibovil. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
macrolabs.in
100%
4.4K#4,690,758View details
camrut.com
91%
1.5K#9,681,078View details
kivonyx.com
86%
3K#5,666,131View details
saphnixlifesciences.com
82%
8.3K#2,439,196View details
sunwinhealthcare.in
80%
10.4K#1,135,306View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Fibovil

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Fibovil

Fibovil was founded in 2019.

Fibovil has 1 employees.

The primary company behind Fibovil, Fibovil Pharmaceuticals Private Limited, reported revenue of β‚Ή36.82 Cr for FY 2025, up 22% year on year.

Fibovil is recognized for offering PCD Pharma franchises and a wide range of pharmaceutical products, with quality assurance maintained through WHOGMPGLP certifications. Over 3000 products are supplied across various therapeutic areas, including tablets, capsules, and injections, to meet patient needs in the Indian market. Research and development efforts are directed towards cost-effective solutions, bridging gaps in healthcare with experienced insights in the sector. Environmental protection is prioritized in manufacturing processes.

Fibovil offers Tablets and PCD Pharma Franchise.

Fibovil operates through Fibovil Pharmaceuticals Private Limited.

The legal entities of Fibovil currently have 3 directors, including Jagat Parkash, Sahil, Reetu Rani.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available